Michelle SidleMichelleSidle

Underwriters in connection with the $60 million follow-on public offering of Amylyx Pharmaceuticals, Inc. in 2025.

McCormick & Company, Inc. in connection with its $500 million public offering of senior notes in 2024.

Underwriters in connection with the $178 million follow-on public offering of Disc Medicine, Inc. in 2024.

Dyne Therapeutics, Inc. in connection with its $374.3 million follow-on public offering in 2024.

Dyne Therapeutics, Inc. in connection with its $345 million follow-on public offering in 2024.

Arvinas, Inc. in connection with its private placement equity financing of approximately $350 million in 2023.

McCormick & Company, Inc. in connection with its $500 million public offering of senior notes in 2023.

Akamai Technologies, Inc. in connection with its purchase of all outstanding equity of Linode for approximately $900 million in 2022.

Petillo Inc. in connection with its sale to Sterling Construction Company for $175 million of cash and 759,447 shares of Sterling Construction Company common shares valued at $20 million in 2022.

Numerous public companies and sales agents in connection with the establishment of “at-the-market” sales arrangements, and other strategic financings.

Numerous SEC reporting companies in connection with Exchange Act compliance and corporate governance matters.